Skip to main content

Table 1 Baseline characteristics of patients in the model construction cohort

From: Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors

 

Values

Subject number

327

Age

44.21 ± 11.22

Gender

  Male

280 (85.63%)

  Female

47 (14.37%)

Liver Histology

 ISHAK Fibrosis Stages

  0

2 (0.61%)

  1

40 (12.23%)

  2

51 (15.60%)

  3

110 (33.64%)

  4

33 (10.09%)

  5

74 (22.63%)

  6

17 (5.20%)

 Piecemeal necrosis

  0

101 (30.89%)

  1

165 (50.46%)

  2

47 (14.37%)

  3

14 (4.28%)

 Confluent necrosis

  0

307 (93.88%)

  1

6 (1.83%)

  2

2 (0.61%)

  3

1 (0.31%)

  4

10 (3.06%)

  5

1 (0.31%)

 Focal (spotty) lytic necrosis, apoptosis and focal inflammation

  0

2 (0.61%)

  1

93 (28.44%)

  2

161 (49.24%)

  3

67 (20.49%)

  4

4 (1.22%)

 Portal inflammation

  0

6 (1.83%)

  1

77 (23.55%)

  2

103 (31.50%)

  3

123 (37.61%)

  4

17 (5.20%)

  5

1 (0.31%)

 Viral serology

  HBV DNA (log10 IU/ml)

6.35 ± 1.71

  HBeAg positive

146 (44.65%)

  HBsAg (log10 IU/ml)

3.33 ± 0.98

 Hematology

  ALT (IU/L)

177.31 ± 173.34

  AST (IU/L)

106.96 ± 122.57

  Bilirubin (mg/dL)

0.98 ± 0.42

  Albumin (g/dL)

4.55 ± 0.35

  Gamma-glutamyltransferase (IU/L)

59.53 ± 46.75

  Platelet (1000/mm3)

189.78 ± 50.31

  Hemoglobin (g/dL)

15.20 ± 1.36